北京
分享至
昂利康公告，公司收到国家药监局签发的头孢氨苄胶囊（0.125g、0.25g）药品补充申请批准通知书，该药品已通过仿制药质量和疗效一致性评价。
本文源自：金融界AI电报
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
